|
[1]The Ministry of Health of the People's Republic of China.Diagnosis and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝肿病杂志,2011,27(11):1141-1159.
|
|
[2] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
|
[3]DOU AH,ZHENG JF,LIU H,et al.The study on incidence of primary hepatic carcinoma of liver cirrhosis patients with type 2 diabetes mellitus[J].Beijing Med J,2013,35(6):412-415.(in Chinese)窦爱华,郑俊福,刘晖,等.肝硬化合并2型糖尿病发生原发性肝癌的风险研究[J].北京医学,2013,35(6):412-415.
|
|
[4]OKA H,YAMAMOTO S,KUROKI T,et al.Prospective study of chemoprevention of hepatoeellular carcinoma with sho-saiko-to(TJ-9)[J].Cancer,1995,76(5):743-749.
|
|
[5]LIU CH,LIU P,HU YY,et al.Progress of clinical and basic research on liver fibrosis with traditional Chinese medicine[J].World Sci Technol Modern Tradit Chin Med,2007,9(2):112-119.(in Chinese)刘成海,刘平,胡义扬,等.中医药抗肝纤维化临床与基础研究进展[J].世界科学技术-中医药现代化,2007,9(2):112-119.
|
|
[6]GU J,ZHANG Q,XUE D,et al.A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis[J].Evid Based Complement Alternat Med,2013,2013:534960.
|
|
[7]LYU J,WANG Q,TAO Y,et al.The mechanism and active components of fuzheng huayu decoction action against liver fibrosis relating to angiogenesis[J].Hepatology,2011,54(Suppl):749-750.
|
|
[8]TANG ZY.My view of improving curative effect of liver cancer[J].Chin J Hepatobiliary Surg,2010,16(8):561-562.(in Chinese)汤钊猷.提高肝癌疗效的我见[J].中华肝胆外科杂志,2010,16(8):561-562.
|
|
[9]WANG LH,CAI HZ,LU Y.Meta analysis on difference between the integrated traditional and western treatment and simple Western medicine treatment on patients with advanced primary liver cancer[J].Anti-Tumor Pharm,2011,1(2):144-148.(in Chinese)王理槐,蔡虎志,陆阳.中晚期原发性肝癌中西医结合治疗与西医治疗疗效比较的Meta分析[J].肿瘤药学,2011,1(2):144-148.
|
|
[10]QIU YW,LIN LZ,HUANG XW,et al.Influence of Chinese medicine on life span of middle-late primary hepatic carcinoma patients:a multicenter retrospective cohort study[J].J Guangzhou Univ Tradit Chin Med,2014,31(5):699-704.(in Chinese)丘奕文,林丽珠,黄学武,等.多中心回顾性队列研究中医药对中晚期原发性肝癌生存期的影响[J].广州中医药大学学报,2014,31(5):699-704.
|
|
[11]YU EX,LIU LM,SONG MZ,et al.Combined moving strip whole liver irradiation and traditional Chinese medicine for large liver cancer[J].Chin J Oncol,1992,14(1):57-59.(in Chinese)于尔辛,刘鲁明,宋明志,等.全肝移动条野放射结合中药治疗大肝癌的临床研究[J].中华肿瘤杂志,1992,14(1):57-59.
|
|
[12]XIONG W,REN ZG,QIU SJ,et al.Residual hepalocellular carcinoma after oxaliplatin treatment has increased metastatic potentia Iin a nude mouse model and is attenuated by songyou yin[J].BMC Cancer,2010,10(1):1-11.
|
|
[13]YANG YK,QIU DZ,WANG GY,et al.Clinical study on Jiawei Yiguanjian for improvement of the survival rate in advanced hepatocellular carcinoma patients[J].Clin Med J China,2011,18(6):818-820.(in Chinese)杨云柯,仇冬则,王国骅,等.中药加昧一贯煎提高原发性肝癌晚期患者生存率的临床研究[J].中国临床医学杂志,2011,18(6):818-820.
|
|
[14]ZHOU YN,MU YP,FU WW,et al.Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice[J].BMC Complement Altern Med,2015,15:342.
|
DownLoad: